Staphylococcal LTA antagonizes the B cell-mitogenic potential of LPS.
Seok-Seong KangSun Kyung KimJung Eun BaikEun Byeol KoKi Bum AhnCheol-Heui YunSeung Hyun HanPublished in: Scientific reports (2018)
Lipoteichoic acid (LTA) of Gram-positive bacteria is regarded as the counterpart biomolecule of lipopolysaccharide (LPS) of Gram-negative bacteria because of their structural and immunological similarities. Although LPS induces a strong polyclonal expansion of B cells, little is known about the effect of LTA on B cell proliferation. In the present study, we prepared LTAs from Gram-positive bacteria and examined their effect on splenic B cell proliferation. Unlike LPS, LTA did not induce B cell proliferation. Instead, Staphylococcus aureus LTA (Sa.LTA) appeared to inhibit LPS-induced B cell proliferation in vitro, ex vivo, and in vivo models. Such effect was observed neither in splenocytes from Toll-like receptor 2 (TLR2)-deficient mice nor in the purified splenic B cells. Furthermore, decreased ERK phosphorylation appeared to be responsible for this phenomenon. Collectively, our results support that Sa.LTA inhibited LPS-induced B cell proliferation through the decrease of ERK phosphorylation via TLR2 signaling pathway.
Keyphrases
- inflammatory response
- cell proliferation
- lps induced
- toll like receptor
- pi k akt
- signaling pathway
- staphylococcus aureus
- cell cycle
- nuclear factor
- immune response
- epithelial mesenchymal transition
- pseudomonas aeruginosa
- climate change
- protein kinase
- anti inflammatory
- risk assessment
- escherichia coli
- methicillin resistant staphylococcus aureus
- human health
- candida albicans